BALFX
Price
$36.72
Change
-$0.26 (-0.70%)
Updated
Aug 1 closing price
Net Assets
251.16B
MTRIX
Price
$19.56
Change
-$0.05 (-0.25%)
Updated
Aug 1 closing price
Net Assets
7.6B
Interact to see
Advertisement

BALFX vs MTRIX

Header iconBALFX vs MTRIX Comparison
Open Charts BALFX vs MTRIXBanner chart's image
American Funds American Balanced F1
Price$36.72
Change-$0.26 (-0.70%)
VolumeN/A
Net Assets251.16B
MFS Total Return I
Price$19.56
Change-$0.05 (-0.25%)
VolumeN/A
Net Assets7.6B
BALFX vs MTRIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALFX vs. MTRIX commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and MTRIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 251B vs. MTRIX (7.6B). MTRIX pays higher dividends than BALFX: MTRIX (2.57) vs BALFX (1.79). BALFX was incepted earlier than MTRIX: BALFX (24 years) vs MTRIX (29 years). BALFX (0.61) is less costly to investors than MTRIX (0.47). MTRIX is a more actively managed with annual turnover of: 53.00 vs. BALFX (44.00). MTRIX has a lower initial minimum investment than BALFX: MTRIX (0) vs BALFX (250). BALFX annual gain was more profitable for investors over the last year : 7.45 vs. MTRIX (-0.22). BALFX return over 5 years is better than : 37.12 vs. MTRIX (11.97).
BALFXMTRIXBALFX / MTRIX
Total Expense Ratio0.610.47130%
Annual Report Gross Expense Ratio0.610.47130%
Fund Existence24 years29 years-
Gain YTD7.6945.129150%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets251B7.6B3,304%
Annual Yield % from dividends1.792.5770%
Returns for 1 year7.45-0.22-3,388%
Returns for 3 years30.739.70317%
Returns for 5 years37.1211.97310%
Returns for 10 years62.2534.37181%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICFI83.89N/A
N/A
ICF International
FATE1.07-0.03
-2.73%
Fate Therapeutics
SYF67.53-2.14
-3.07%
Synchrony Financial
BFRI1.04-0.04
-3.70%
Biofrontera
INNV3.13-0.19
-5.72%
InnovAge Holding Corp